US Forensic Genomics Market Size Likely to Grow at a CAGR of 16.35% By 2034

Market Size and Growth

As per the US Forensic Genomics Market size analysis conducted by the CMI team, the US forensic genomics market is expected to record a CAGR of 16.35% from 2025 to 2034. In 2025, the market size was USD306.78 Million. By 2034, the valuation is anticipated to reach USD 1192.35 Million.

Overview

As per the industry experts at TMR, the U.S. forensic genomics market is likely to witness an exponential CAGR during the forecast period. This could be attributed to rise in crime rates, expansion of the DNA databases for resolution of cold cases and identification of suspects, and technological advancements such as next-generation sequencing (NGS). At the same time, the challenges faced include integrating regulatory compliance and ethical standards, which are important for sustainable growth and public trust.

Key Trends & Drivers

• Increased Crime Rates and Technological Advancements to Determine Growth: Rising incidences of criminal activities (violent crimes in particular) are driving the demand for advanced forensic tools on a direct basis with the objective of identifying predators. Innovations in bioinformatics and DNA sequencing, encompassing the development of AI-driven analysis tools and NGS, do improve the accuracy and speed of the genetic data interpretation. Cloud-based platforms are gaining popularity owing to their scalability and secured data storage capacities.

• DNA Databases to Catalyze the Market: Expansion as well as utilization of the national DNA databases enable speedy matching of the samples, thereby enhancing precision and efficiency of the investigations. The governments are also heavily investing in technology infrastructure and forensic science, thereby extending support to the growth of the U.S. forensic genomics market.

Report Scope

SWOT Analysis

• Strengths: Advancements in technologies such as AI and NGS enhance efficiency and precision in DNA analysis. Both the private and government sectors are increasingly investing, thereby improving forensic capabilities. Also, growing reliance by law enforcement agencies on genomic technologies is catalyzing market growth.

• Weaknesses: Limited budgets in certain forensic labs are likely to slow down the adoption of novel technologies. Also, there is a need for qualified professionals for effectively operating forensic genomics tools and interpreting complex data. The growth of the U.S. forensic genomics market is bound to slow down forthwith.

• Opportunities: Integrating forensic genealogy techniques is likely to expand the role of genomics with regard to finding leads. AI integration does offer opportunities to recognize complex patterns along with proffering automated data interpretation and predictive analytics. Cloud platforms do enable remote access, data storage, and collaboration, thereby addressing the rising need for scalable solutions.

• Threats: Cost of implementation of advanced technologies could be challenging for certain agencies. Also, using sensitive genetic data on an extensive note is likely to raise concerns regarding privacy and security. Also, ascertaining the ongoing precision and validity of new and current forensic methods is a challenge.

List of the prominent players in the US Forensic Genomics Market:

• Illumina Inc.
• Thermo Fisher Scientific Inc.
• Merck KGaA
• Agilent Technologies
• Promega Corporation
• QIAGEN
• Bio-Rad Laboratories
• LGC Limited
• Tri Tech Forensics
• Verogen
• Others

The US Forensic Genomics Market is segmented as follows:

By Product

• Analyzers & Sequencers
• Software
• Kits & Consumables

By Method

• Capillary Electrophoresis
• Next-generation Sequencing
• PCR Amplification

By Application

• Criminal Testing
• Paternity & Familial Testing

[embedsocial_reviews id=”d4ae80cffae3d938f997111953699a733c8e6f99″]